FindTrial
Sign In

Clinical Study on Prognosis and Curative Effect of Breast Cancer, Colorectal Carcinoma and Advanced Lung Cancer Using Circulating Tumor Cells and Molecular Classification

Clinical Study on Prognosis and Curative Effect of Breast Cancer, Colorectal Carcinoma and Advanced Lung Cancer Using Circulating Tumor Cells and Molecular Classification

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17010549
Enrollment
Unknown
Registered
2017-02-04
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Carcinoma and Advanced Lung Cancer

Interventions

Lung cancer group:Detection of CTC
Colorectal cancer group:Detection of CTC
Breast cancer group: Detection of CTC

Sponsors

Department of Oncology, Shenzhen Second People's Hospita
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. Clinical evaluation: cIII-IV of breast cancer, colorectal cancer and lung cancer patients; 3. Clinical and radiographic assessment of non-surgical, need to receive systemic treatment such as chemotherapy or targeted therapy.

Exclusion criteria

Exclusion criteria: 1. suffering from severe vascular disease; 2. cases of incomplete data, comprehensive diagnosis of the sample is not clear.

Design outcomes

Primary

MeasureTime frame
CTC;OS;Recurrence rate;—

Countries

China

Contacts

Public ContactLiang Xiao

Department of Oncology, Shenzhen Second People's Hospital

9179320@qq.com+86 13554764527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026